November 13, 2012
Subsidiaries of Merck & Co. Inc. and Takeda Pharmaceutical Co. Ltd on Friday sued Fresenius SE & Co. KGaA's U.S. entities for patent infringement in Delaware court, seeking to block their plans to market a generic version of blood thinner Integrilin.